JPH0214360B2 - - Google Patents

Info

Publication number
JPH0214360B2
JPH0214360B2 JP55069079A JP6907980A JPH0214360B2 JP H0214360 B2 JPH0214360 B2 JP H0214360B2 JP 55069079 A JP55069079 A JP 55069079A JP 6907980 A JP6907980 A JP 6907980A JP H0214360 B2 JPH0214360 B2 JP H0214360B2
Authority
JP
Japan
Prior art keywords
dimethylene
formula
androstadien
perhydrofuran
dione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP55069079A
Other languages
English (en)
Japanese (ja)
Other versions
JPS55162799A (en
Inventor
Uiihieruto Rudorufu
Bitsutoraa Deiitaa
Kerupu Ururitsuhi
Puretsueuofusukii Kurausu
Kazarusu Shutentsueru Yoruge
Rozeruto Uorufugangu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS55162799A publication Critical patent/JPS55162799A/ja
Publication of JPH0214360B2 publication Critical patent/JPH0214360B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Control Of High-Frequency Heating Circuits (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP6907980A 1979-05-31 1980-05-26 6beta* 7beta* 15*166dimethylenee1*44 androstadienee33one* its manufacture and antiandrosterone medicine blend containing it and having antihypertensive and diuretic activity Granted JPS55162799A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792922500 DE2922500A1 (de) 1979-05-31 1979-05-31 6 beta .7 beta

Publications (2)

Publication Number Publication Date
JPS55162799A JPS55162799A (en) 1980-12-18
JPH0214360B2 true JPH0214360B2 (en, 2012) 1990-04-06

Family

ID=6072347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6907980A Granted JPS55162799A (en) 1979-05-31 1980-05-26 6beta* 7beta* 15*166dimethylenee1*44 androstadienee33one* its manufacture and antiandrosterone medicine blend containing it and having antihypertensive and diuretic activity

Country Status (16)

Country Link
US (1) US4291029A (en, 2012)
EP (1) EP0019690B1 (en, 2012)
JP (1) JPS55162799A (en, 2012)
AT (1) ATE880T1 (en, 2012)
AU (1) AU531057B2 (en, 2012)
CA (1) CA1134814A (en, 2012)
CS (1) CS214712B2 (en, 2012)
DD (1) DD151172A5 (en, 2012)
DE (2) DE2922500A1 (en, 2012)
DK (1) DK145140C (en, 2012)
ES (1) ES8101082A1 (en, 2012)
HU (2) HU181714B (en, 2012)
IE (1) IE49899B1 (en, 2012)
IL (1) IL60185A (en, 2012)
SU (1) SU873890A3 (en, 2012)
YU (1) YU41926B (en, 2012)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3111951A1 (de) * 1981-03-23 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen 7(alpha)-alkoxycarbonyl-15ss-methylen-4-androstene, verfahren zu ihrer herstellung und verwendung als arzneimittel
DE3213962A1 (de) * 1982-04-13 1983-10-13 Schering AG, 1000 Berlin und 4709 Bergkamen 1(alpha).2(alpha);6(beta).7(beta).15(beta).16(beta)-trimethylen-3-oxo-17(alpha)-pregn-4-en-21.17-carbolacton, dessen herstellung und verwendung als arzneimittel
DE3222265A1 (de) * 1982-06-09 1983-12-15 Schering AG, 1000 Berlin und 4709 Bergkamen 6ss.7ss-methylen-17(alpha)-pregn-4-en-21.17-carbolactone, verfahren zu ihrer herstellung und verwendung als arzneimittel
DE3227598A1 (de) * 1982-07-22 1984-01-26 Schering AG, 1000 Berlin und 4709 Bergkamen 7(alpha)-acylthio-15.16-methylen-3-oxo-17(alpha)-pregna-1.4-dien-21,17-carbolactone, verfahren zu ihrer herstellung und verwendung als arzneimittel
JPS5921698A (ja) * 1982-07-22 1984-02-03 シエ−リング・アクチエンゲゼルシヤフト １７α−プレグネ−４−エン−３−オキソ−２１−カルボン酸エステル、その製法およびこれを含有する抗アンドロゲン作用を有する医薬
DE3240510A1 (de) * 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 7(alpha)-acylthio-1(alpha),2(alpha)-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, deren herstellung und diese enthaltende arzneimittel
FI77669C (fi) * 1983-04-13 1989-04-10 Ciba Geigy Ag 20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat.
DE3326013A1 (de) * 1983-07-15 1985-01-24 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-methylen-17(alpha)-pregna-4,6-dien-21-carbonsaeuresalze, diese enthaltende pharmazeutische praeparate sowie verfahren zu deren herstellung
ATE51233T1 (de) * 1983-08-17 1990-04-15 Schering Ag 7-alpha-substituierte 3-oxo-17alpha-pregn-4-en21.17-carbolactone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
FR2697328A1 (fr) * 1992-10-23 1994-04-29 Giat Ind Sa Munition fumigène.
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027635A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063498A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063499A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft Steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063495A1 (de) 2007-12-29 2009-09-17 Bayer Schering Pharma Aktiengesellschaft 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
DE102007063501A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15, 16-Methylen-17-hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063500A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063496A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102008026793A1 (de) 2008-06-02 2009-12-03 Bayer Schering Pharma Aktiengesellschaft C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
CA2854215A1 (en) 2011-11-04 2013-05-10 Bayer Pharma Aktiengesellschaft 18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17.beta.-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosis
WO2016063269A1 (en) 2014-10-20 2016-04-28 Prendergast Patrick T Use of antagonists to the nuclear steroid receptor alone or in combination as direct antiviral agents to inhibit alphavirus, togaviridae, arenaviridae, filoviridae, bunyaviridae, flaviviridae and rhabdoviridae

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3254074A (en) * 1962-04-25 1966-05-31 Merck & Co Inc Spiroxenones
DE2264189C3 (de) * 1972-12-29 1979-05-31 Merck & Co., Inc., Rahway, N.J. (V.St.A.) 3'-(3-Oxo-17beta-hydroxy-6,7-methylen-androst-4en-bzw.-l,4-dien-17 a-yl) -propionsäureverbindungen, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
ES469510A1 (es) * 1977-05-16 1978-12-01 Schering Ag Procedimiento para la preparacion de 17beta hidroxi-4-an- drosten-3-onas.

Also Published As

Publication number Publication date
ATE880T1 (de) 1982-05-15
CS214712B2 (en) 1982-05-28
DK145140B (da) 1982-09-13
IE49899B1 (en) 1986-01-08
IL60185A0 (en) 1980-07-31
IL60185A (en) 1983-06-15
YU132980A (en) 1983-02-28
IE801127L (en) 1980-11-30
HU181714B (en) 1983-11-28
DD151172A5 (de) 1981-10-08
CA1134814A (en) 1982-11-02
DK145140C (da) 1983-02-21
SU873890A3 (ru) 1981-10-15
EP0019690B1 (de) 1982-04-21
ES491916A0 (es) 1980-12-16
HU187419B (en) 1986-01-28
AU531057B2 (en) 1983-08-11
DE3060297D1 (en) 1982-06-03
EP0019690A1 (de) 1980-12-10
JPS55162799A (en) 1980-12-18
US4291029A (en) 1981-09-22
YU41926B (en) 1988-02-29
DE2922500A1 (de) 1980-12-04
AU5874580A (en) 1980-12-04
ES8101082A1 (es) 1980-12-16
DK234780A (da) 1980-12-01

Similar Documents

Publication Publication Date Title
JPH0214360B2 (en, 2012)
JPH0242840B2 (en, 2012)
JPS596880B2 (ja) Ｄ−ホモステロイドの製造方法
Edwards et al. Steroids. CXXXVI. 1 Synthesis of a new class of potent cortical hormones. 6α-fluoro-and 6α, 9α-difluoro-16α-methylprednisolone and related steroids2
JPH0372080B2 (en, 2012)
US2888457A (en) Bismethylenedioxy steroids and methods of making same
US3194803A (en) Process and intermediates for the manufacture of 3-keto-delta4, 6 steroids
JPS6052160B2 (ja) プレグナン系のｄ−ホモステロイドの製造方法
US3423433A (en) Method of producing 3-keto-4,6-bisdehydro-6-halogeno-9beta,10alpha-steroids
US3707537A (en) 4-chloro-4,6-diene-6-halo or lower alkyl steroids
JPH0411558B2 (en, 2012)
JPS59205400A (ja) ２０−スピロキサン系ステロイド及びその製造方法並びに該ステロイドを含有する医薬
US3349084A (en) Steroidal [16, 17-d]-2'-isoxazolines of the pregnane series
US3251863A (en) Steroidguanylhydrazones
Poos et al. Approaches to the Total Synthesis of Adrenal Steroids. XI. Dehydrocorticosterone and Cortisone
CA1058610A (en) 17a, 21-diesters of the pregnane series
Mills et al. Steroids. CXLIV. Synthesis of some 6α, 17α-dihaloprogesterones
US3182075A (en) 17-substituted 19-norpregna-1, 3, 5(10), 6, 8-pentaen-20-ones
US3269910A (en) 3(beta-hydroxyethyl)-iminosteroids of the pregnane series and methods of admin-istration
Wiley et al. Steroid dimethylhydrazones
US3828083A (en) Novel 6alpha,16alpha-dimethyl steroids
US3466371A (en) 1,2alpha-methylene-steroids and process for their production
US3629302A (en) 6-chloro-20-substituted-pregnanes
US3665017A (en) Process for preparation of 6-azido-4,6-bis-dehydro-steroids
US3408369A (en) 2-substituted-3-keto-delta4, 6-9beta, 10alpha-steroids